2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
5
Prostatic Neoplasms
2
Motor Activity
2
Stress, Psychological
1
Neoplasms, Hormone-Dependent
1
Musculoskeletal Pain
1
Medication Adherence
1
Disease
1
Depression
1
Chronic Pain
1
Anxiety Disorders
1
Interventions
Morphine
7
Surveys and Questionnaires
6
Ketamine
5
Fentanyl
4
Sodium Chloride
3
Saline Solution
3
Lidocaine
3
Educational Status
3
Dexmedetomidine
3
Cognitive Behavioral Therapy
3
Anesthetics, Local
3
ziconotide
2
Pregabalin
2
Mindfulness-Based Stress Reduction
2
Hypnosis
2
Control Groups
2
Bupivacaine
2
Acetaminophen
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tianeptine
1
siltuximab
1
onabotulinum toxin A
1
nabiximols
1
morphine, naltrexone combination
1
erenumab
1
Yoga
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Tramadol
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chronic Pain
×
Self-Management
×
Clear all
NCT06174246
2024-01-09
PEPO
Laval University
Phase NA
Unknown
86 enrolled